Paxir Oral Spray

Different Phases of Product Studies:

1. Library Studies and Comprehensive Source Review:

Examination of literature on preparation methods, production techniques, and product impact on diseases.

2. Phytochemical Analysis and Compound Identification:

Utilizes GC-MS and spectrophotometry for precise identification of product compounds.

3. Product Bioinformatics Studies:

Molecular docking of effective compounds against key coronavirus receptors.

4. Formulation Mastery:

Innovative formulation processes, including nanoextracts and precise homogenization.

5. Conducting Research Experiments:

Establishment and standardization of extraction and formulation methodologies.

Product Features:

1. Natural Ingredients:

Appeals to consumers seeking natural alternatives.

2. Nano Ingredients:

Nano-sized active ingredients enhance efficacy against microbes.

3. Rapid Microbial Reduction:

Achieves a four logarithmic reduction in coated viruses within 30 seconds, indicating quick and potent action.

4. Reduced Active Ingredient Amount:

Formulated to minimize active ingredient quantity for a balance between effectiveness and resource conservation.

5. Throat Relief:

Alleviates inflammation and throat roughness, addressing respiratory discomfort.

6. Spray Formulation:

Easy-to-use spray formulation with a nozzle for convenient application.

7. No Side Effects or Toxicity:

Non-cytotoxicity and inhalation tests demonstrate product safety, with no adverse effects on healthy cells.

8. Immune System Boost:

Contains compounds contributing to an increase in the body’s immune system.

9. Affordability:

Positioned at a low price point compared to similar foreign products, offering a cost-effective solution.

10. Domestic Production:

100% production of raw materials within the country, supporting local industries and potentially ensuring quality control.

Introduction:

Paxir Spray is proudly produced by Exir Faravaran Sabalan Company, a knowledge-based company operating under the Scientific Vice President of Iran. Specializing in the production of natural products, including medicines and supplements, the company is committed to delivering high-quality solutions rooted in science and innovation.

Paxir Spray, a flagship offering, has positioned itself as a medicinal solution targeting throat inflammation and roughness. Its efficacy is attributed to a combination of key features, emphasizing the natural composition of active ingredients, the utilization of nano-technology, and its notable effectiveness against microbes.

Paxir Spray has secured all requisite laboratory approvals and licenses from the esteemed FDA (Food and Drug Administration of Iran). This serves as irrefutable evidence of its commitment to stringent safety and quality standards. The product proudly holds IRC number 7779207227173694, confirming its compliance with legal requirements and further enhancing its credibility.